glp 1 kidney protection Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine GLP-1 and the kidney: from

Sachan DS, Rhew TH, Ruark RA

SGLT2-i induced natriuresis and glomerular hemodynamics changes resemble, even partially, those observed with sacubitril/valsartan, a first in-class angiotensin receptor neprilysin inhibitor (ARNi)

Enjoy free Shipping

The current work demonstrates that NHPN-1010 significantly improves all assessed outcome measures relative to vehicle, suggesting that the delayed therapeutic approach is highly effective in addressing NIT in this model, including its associated cochlear synaptopathy and central auditory processing deficits

doi: 10.1159/000330447 74 HegedsLShermanSITuttleRMvon ScholtenBJRasmussenSKarsblJDet al